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receptive MHC I molecules are generated, far less is
known about the pre- and postTAP steps that antigenic
precursors undergo to yield the final peptide products
presented by MHC I molecules.
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Berkeley, California 94720 that is defined by size and conserved sequence motifs
(Rammensee et al., 1995). For a given antigenic precur-
sor, a particular MHC I molecule generally presents a
precisely cleaved, homogenous peptide on the cell sur-Summary
face (Van Bleek and Nathenson, 1990; Falk et al., 1991).
For example, in cells expressing the ovalbumin protein,The antigen processing pathway generates the pep-
tides displayed by MHC I molecules on the cell surface. the Kb MHC I presents the SIINFEKL (SL8) octapeptide
(Rotzschke et al., 1991; Malarkannan et al., 1995). TheWhether these peptides are generated in the cytosol
or from longer intermediates transported into the ER SL8 peptide shares the sequence motif xxxx(F,Y)x-
x(I,M,L) with many other peptides presented by the sameis unclear, because peptides other than those bound
to MHC I have been difficult to find. Using a novel Kb MHC. The Db MHC I molecule, on the other hand,
generally presents nonamer peptides that conform toassay, we show that N-terminally extended antigenic
analogs were associated with high±molecular weight the motif xxxx(N)xxx(I,L,M) (Falk et al., 1991). In principle,
the cells could generate these sets of exactly cleavedmaterial in the cytosol and were transported by TAP.
In the ER, a nonapeptide was predominant that was 8- to 11-mer peptides either in the cytosol itself, where
the antigen processing pathway begins (Monaco andconverted to the final octapeptide only in presence
of the appropriate MHC I molecule. The existence of Nandi, 1995), or they could generate a set of extended
peptides that, following TAP transport, could be trimmedextended peptides and their MHC I±dependent trim-
ming suggest a mechanism for efficiently satisfying in the ER to the appropriate length (Falk et al., 1990).
Support for the former model comes from in vitro assaysthe distinct sequence preferences of polymorphic
MHC I molecules. using model substrates which showed that optimally
cleaved peptide fragments can, albeit inefficiently, be
generated by the cytosolic proteases (Niedermann etIntroduction
al., 1995; Dick et al., 1996; Beninga et al., 1998), and
that these peptides are within the size range suitableAntigen processing and presentation is a series of
for TAP-mediated transport into microsomes (Neefjesevents that culminates in the display of peptides bound
et al., 1993; Androlewicz and Cresswell, 1994; Heemelsto major histocompatibility complex class I (MHC I) on
and Ploegh, 1994). However, whether these perfectlythe cell surface. The peptide/MHC I complexes serve
cleaved peptides are actually produced in the cytosolas the ligands for CD8 T cells that recognize target cells
and transported by TAP in living cells has not beendisplaying peptides originating from viral or bacterial
established. To the contrary, attempts to isolate natu-pathogens, tumor-specific genes, or polymorphic histo-
rally processed peptides from cells expressing the anti-compatibility loci. Most antigen precursors are initially
genic precursor in the absence of the restricting MHCfragmented into peptides in the cytosol by the multicata-
I molecule have consistently failed (Falk et al., 1990;lytic proteasome as well as other proteases (Rock and
Malarkannan et al., 1995), with the single exception, toGoldberg, 1999). Cytosolic peptides that meet the size
our knowledge, of the Kb-restricted NP peptide that wasand sequence requirements of the peptide transporter
isolated from VSV-infected H-2d cells (Nieland et al.,TAP are then delivered into the lumen of the endoplas-
1996). Assuming that the antigenic peptides were notmic reticulum (ER), where they are loaded onto appro-
simply inaccessible to the extraction procedures used,priate MHC I molecules. (York and Rock, 1996; Pamer
these results imply that the MHC I molecules exert aand Cresswell, 1998). Most empty MHC I molecules,
profound influence on the cellular composition of anti-associated with calreticulin and the ERp57 molecule,
genic peptides (Falk et al., 1990). Whether the role ofare tethered to TAP by tapasin (Sadasivan et al., 1996;
MHC I is to protect the extraordinarily labile peptidesOrtmann et al., 1997; Hughes and Cresswell, 1998). Upon
from further destruction or to guide the trimming of extrapeptide binding, the MHC I molecules are released from
flanking residues to generate the precisely cleaved pep-this multimeric complex and transported to the cell sur-
tides seen in HPLC fractionated cell extracts or in pep-face through the secretory pathway. The peptide loading
tide/MHC crystals has not been resolved. Furthermore,event, centered at the TAP1/TAP2 heterodimer, thus
without the ability to detect the proteolytic intermediatesrepresents the convergence of two separate pathways:
in the antigen processing pathway, it is not known whichone generating the antigenic peptides and another gen-
peptide fragments are actually generated from a givenerating the peptide-receptive MHC I molecules. In con-
antigenic precursor, whether these proteolytic interme-trast to our considerable understanding of how peptide
diates are bound or free in the cytosol, and what their
fate is in the ER in the presence or absence of the* To whom correspondence should be addressed (e-mail: nshastri@
socrates.berkeley.edu). restricting MHC I molecules.
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Figure 1. Trypsin Treatment Dramatically Enhances the Antigenic Activity of N-Terminally Extended zK-SHL8 Analogs and Allows Their
Detection in a Complex Peptide Extract
(A) The SIINFEHL (SHL8) synthetic peptide analogs, with one to three additional N-terminal residues indicated in single letter amino acid code,
were digested with active (plus) or DEPC-inactivated trypsin (minus) for 3 hr at 378 and added to 3 3 104 Kb-L cells as APC and 1 3 105
SHL8/Kb-specific B3Z T cell hybridoma cells. After overnight culture, the activation of the B3Z cells was measured as the induction of
b-galactosidase activity using the chlorophenol red b-pyranoside substrate. The absorbance of the colored product was measured at
595 nm.
(B) Two femtomoles of each of the indicated peptides was added to an acid extract of COS cells, passed through a 10 kDa cut-off filter, and
fractionated by reverse-phase HPLC as described in Experimental Procedures. Individual fractions were treated with inactivated (ªMockº) or
active trypsin (ª1Trypsinº) and assayed as in (A). The reproducible elution time for each peptide, marked by vertical arrows, was determined
with synthetic peptides that were run and assayed under identical conditions.
To address these questions, we have devised enzy- detected by their ability to stimulate CD8 T cell re-
sponses. In contrast to the naturally processed peptidesmatic methods to analyze the intracellular, naturally pro-
cessed peptide pool in the antigen processing pathway eluted from MHC I, which are active at subpicomolar
concentrations in the conventional T cell assay, their(Serwold and Shastri, 1999). The conventional T cell
activation assays used for detecting antigenic peptides analogs with additional N- or C-terminal residues are
essentially inactive (Shastri and Gonzalez, 1993; Ser-are remarkably insensitive when peptide length is in-
creased by even a single residue. We reasoned that wold and Shastri, 1999). This remarkable difference in
the sensitivity of this assay could be increased if the activity of the optimal versus longer peptides has made
optimally active peptide was enzymatically released it very difficult to detect the putative proteolytic interme-
from its extended analogs. This was accomplished by diates in cell extracts, because they are necessarily
introducing a trypsin cleavage site at the N terminus of longer than the precisely cleaved final peptide product.
the naturally processed peptide in its precursor and To overcome this limitation, we developed an enzymatic
treating the HPLC-fractionated cell extracts with trypsin method for detecting antigenic analogs of the oval-
before the T cell assay. Analysis of cell extracts by this bumin-derived SIINFEKL (SL8) octapeptide that is the
HPLC/trypsin method revealed several distinct proteo- naturally processed product presented by the Kb MHC
lytic intermediates that were generated in the cytosol I molecule. First, the p7 lysine (K) residue was replaced
and were bound to high±molecular weight material. with the histidine (H) residue in the SL8 sequence to
Some of these fragments were selectively transported yield the SIINFEHL (SHL8) peptide. This K7H substitu-
via TAP and were further trimmed in the ER. Strikingly, tion within the antigenic SL8 peptide does not affect the
in the ER the conversion of the predominant nonamer recognition of the SHL8/Kb complex by the B3Z T cell
to the final octapeptide product occurred only in the and also makes the SHL8 peptide refractory to trypsin
presence of the appropriate MHC I molecule. These cleavage. Second, the natural glutamic acid residue at
findings show that proteolysis of antigenic precursors the N-terminal flanking position was replaced with the
occurs both in the cytosol and in the ER and suggest a lysine (K) residue. These substitutions were designed
mechanism for efficiently satisfying the widely varying to allow the release of the optimally active SHL8 pep-
peptide-binding preferences of the polymorphic MHC I tide from its poorly active analogs containing additional
molecules. N-terminal flanking residues after treatment with trypsin,
which specifically cleaves at the carboxyl end of lysine
Results residues. Indeed, this strategy allowed a 100- to 10,000-
fold increase in the sensitivity of the B3Z T cell activation
assay for detecting the peptides with one to three addi-An Assay for Detecting Proteolytic Intermediates
In the presence of appropriate APC, antigenic peptides tional N-terminal flanking residues (Figure 1A). Further,
when a cell extract spiked with only 2 fmol of each ofbind to MHC I molecules on the cell surface and can be
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Figure 2. Schematic Representation of the n90K-SHL8 Precursor and Its Efficient Processing to the SHL8/Kb Complex in a TAP-Dependent
Manner
(A) Schematic representation of the n90K-SHL8 precursor, a fusion between the invariant chain (aa 1±80) and ovalbumin (OVA) residues
247±265. The cytosolic tail, transmembrane, and ER lumenal regions are indicated. The OVA residues were substituted (E257K, K264H) to
allow the release of the optimally active SIINFEHL (SHL8) peptide from poorly active putative proteolytic intermediates (zK-SHL8) by trypsin
treatment.
(B±D) Presentation of SHL8/Kb complex to B3Z T cells in transfected COS cells without or with the TAP inhibitor ICP47. COS cells (5 3 104)
were transfected with 50 ng/ml Kb cDNA and varying concentrations of vector DNA or the indicated antigen DNA constructs (full-length
OVA1±386, OVA1±265, Met-SHL8, n90K-SHL8, or the ER-targeted esMK-SHL8) in 96-well plates. Two days later, B3Z (1 3 105) T cells were
added to each culture, and after an overnight incubation, their lacZ activity was measured as in the legend for Figure 1. In (C) and (D), the
TAP inhibitor ICP47 expression plasmid (1 mg/ml, filled symbols) or vector DNA (open symbols) was included during transfection.
the four peptides was fractionated by reverse-phase transfected with the TAP inhibitor ICP47 (Fruh et al.,
1995; Hill et al., 1995). Coexpression of ICP47 inhibitedHPLC and treated with inactive trypsin, only the SHL8
and the K-SHL8 peptides were detected in the T cell the B3Z T cell stimulation activity generated from both
the cytosolic M-SHL8 minigene and the n90-K-SHL8assay (Figure 1B). However, after each HPLC fraction
was treated with active trypsin, all four peptides were constructs by over 100-fold (Figure 2C). In contrast, the
B3Z stimulating activity of cells expressing the ER-tar-detected in appropriate fractions. Thus, trypsin treat-
ment of HPLC fractions overcomes the limitations in geted construct esM-K-SHL8 was not inhibited and ac-
detecting the poorly active, N-terminally extended SHL8 tually increased in the presence of ICP47 (Figure 2D).
analogs and allows their identification based upon their Presentation of the SHL8/Kb complex from the ER-tar-
reproducible HPLC retention times. geted n90-K-SHL8 precursor was therefore TAP depen-
dent, indicating that it was processed in the cytosol,
The n90K-SHL8 Is a TAP-Dependent Precursor either because a fraction of the translated protein failed
for Generating the SHL8/Kb Complex to translocate into the ER or because it was retrieved
With the goal of analyzing putative proteolytic intermedi- from the ER for degradation in the cytosol (Skipper et
ates generated during antigen processing using the al., 1996; Snyder et al., 1997). The n90-K-SHL8 was cho-
HPLC/trypsin method, we tested different antigenic pre- sen as a model precursor because it was processed
cursors in an endogenous presentation assay. COS cells efficiently in a conventional TAP-dependent manner and
were cotransfected with Kb cDNA together with the plas- because its SHL8-containing putative proteolytic inter-
mid vector alone, the minigene M-SHL8, full-length OVA, mediates could be detected with the HPLC/trypsin
the OVA1±265 fragment, or a fusion protein containing method described above.
the SHL8 peptide at the carboxyl end of the invariant
chain fragment (n90-K-SHL8) (Figure 2A). The highest
Proteolytic Intermediates in the CytosolB3Z T cell±stimulating activity was observed with con-
and Membrane Compartmentsstructs encoding the minimal M-SHL8 peptide and the
To determine whether proteolytic intermediates actuallyn90-K-SHL8 fusion protein (Figure 2B). To determine
exist in the MHC I antigen processing pathway, wewhether the n90-K-SHL8 precursor, as a type 2 trans-
generated stable FO-1 transfectants expressing themembrane protein (Sanderson et al., 1995), was pro-
cessed in the ER or in the cytosol, the cells were also n90-K-SHL8 construct. The FO-1 cell line is derived
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Figure 3. Discrete Proteolytic Intermediates
Are Generated from the n90K-SHL8 Precur-
sor in the Cytosol and in the ER
The cytosolic peptides are recovered as
high±molecular weight species. The n90K-
SHL8-transfected FO-1 cells were homoge-
nized and centrifuged at 100,000 3 g to sepa-
rate the supernatant (SNF/cytosol) from the
membrane compartments (100K pellet).
(A) Western blot of the supernatant and pellet
fractions with antibodies specific for the ER-
resident calnexin or the cytosolic hsp27 pro-
teins. Each lane represents 105 cell equiva-
lents.
(B and C) Antigenic peptides were acid ex-
tracted from the cytosol or the pellet by boil-
ing in 10% formic acid, passed through a 10
kDa molecular weight cut-off filter, and frac-
tionated by reverse phase HPLC. Each frac-
tion was digested with trypsin and assayed
for B3Z T cell stimulating activity as de-
scribed in the legend to Figure 1. The arrows
indicate the elution time of synthetic peptides
run under identical conditions.
(D and E) The cytosol fraction was passed
over the 10 kDa cut-off filter without acid ex-
traction to separate free from bound pep-
tides. Peptides were then extracted from the
filtrate (,10 kDa cytosol) and the retentate
(.10 kDa cytosol), fractionated by HPLC, and
analyzed for antigenic activity.
from a human melanoma and does not express endoge- ER that were generated in the absence of any functional
MHC I molecules. Most importantly, the peptide compo-nous b2-microglobulin (D'Urso et al., 1991). As a conse-
quence, the endogenous MHC I molecules cannot as- sition of the cytosol was distinct from that of the mem-
brane fraction, with little if any SHL8 peptide in eithersemble in FO-1 cells, which permits analysis of antigen
processing events in the complete absence of functional compartment. Similar results were also obtained in hu-
man HeLa and mouse P815 (H-2d) cells transfected withMHC I molecules. To analyze putative peptide intermedi-
ates, the FO-1 cells were homogenized and separated the same precursor (data not shown), indicating that
the composition of the cytosolic and ER peptides wasinto the 100,000 3 g (100K) pellet containing the mem-
brane compartments and the 100K supernatant repre- similar in human and mouse cells and was not influenced
by a variety of different MHC I molecules expressed insenting soluble cytosol. Western blot analysis confirmed
that, as expected, the 100K pellet was enriched for cal- these cells. Additionally, N-terminally extended antigenic
peptides but not the naturally processed analog werenexin, an ER-resident protein, while the cytosolic hsp27
protein was detected only in the supernatant fraction also recovered from FO-1 and COS cells expressing the
n90-K-precursor appended with another Kb-restricted(Figure 3A).
The antigenic peptides in the 100K pellet and the peptide.
cytosol were extracted by boiling in 10% formic acid,
passed through a 10 kDa molecular weight cut-off filter,
and analyzed for the presence of B3Z-stimulating SHL8 Cytosolic Peptides Are Associated with High±
Molecular Weight Materialanalogs by the HPLC/trypsin method described above.
Two dominant and three smaller activity peaks were The ability to detect the LK-SHL8 and QLK-SHL8 pep-
tides in the cytosol provided an opportunity to charac-detected in the cytosol extract (Figure 3B). One of the
major (fractions 18±20) and a minor (fractions 28±29) terize the naturally processed preTAP peptides. To de-
termine if these cytosolic peptides existed in a free orpeak of activity coeluted with the LK-SHL8 10-mer and
the QLK-SHL8 11-mer peptides, respectively. The inter- bound state, the cytosol was passed through a 10 kDa
molecular weight cut-off filter before acid extraction andmediate (fractions 34±35) and late-eluting activity peaks
(fractions 43±50) have not yet been assigned. Notably, analysis of the peptides by the HPLC/trypsin method.
Free peptides should have flowed through the 10 kDathe optimally active SHL8 as well as the K-SHL8 nona-
peptide were not detected in the cytosol. In contrast, filter, while the bound peptides would have remained in
the .10 kDa retentate. Significantly, no peptides werethe K-SHL8 peptide was the predominant peptide in the
extract of the 100K pellet that includes the ER compart- detected in the ,10 kDa filtrate (Figure 3D), and virtually
all the peaks observed in the total cytosolic extract werement (Figure 3C). Small amounts of antigenic activity
were also detected in the late HPLC fractions as well present in the extract of the .10 kDa material (Figures
3E versus 3B). We conclude that none of the cytosolicas in peaks coeluting with SHL8 and LK-SHL8 peptides.
The HPLC/trypsin method thus revealed the existence peptides detected were free but were bound to high±
molecular weight species.of proteolytic intermediates in both the cytosol and in the
Proteolytic Events during MHC I Antigen Processing
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Figure 4. The LK-SHL8 Peptide Is the Pre-
dominant Antigenic Activity in the Cytosol
and Is Associated with 30±60 kDa Species
The cytosol from Kb-HeLa cells expressing
the n90K-SHL8 precursor was prepared as in
Figure 3, resuspended in 0.5% NP-40, and
fractionated by size-exclusion HPLC (SEC-
HPLC).
(A and B) Each fraction was tested for (A)
B3Z-stimulating activity after acid-extraction
and (B) the molecular weight of the constit-
uent proteins by running an aliquot in a 12%
SDS-PAGE gel. The proteins were transferred
onto a nitrocellulose and stained with Pon-
ceau S.
(C) Fractions 15 and 16 from the SEC-HPLC
run were pooled, acid extracted, and fraction-
ated by reverse-phase HPLC (RP-HPLC). Se-
rial dilutions of each fraction were treated
with trypsin, and the concentration of anti-
genic peptides was determined by compari-
son with synthetic LK-SHL8 peptide standard
curve.
(D) The Western blot in (B) was probed with
anti-hsp70 and anti-hsp27 antibodies. Mo-
lecular weight standards are indicated on the
left, and the hsp70 and hsp27 bands (arrows)
are indicated on the right.
Previous studies have indicated that antigenic pep- predominant cytosolic LK-SHL8 proteolytic interme-
diate was associated with a high±molecular weighttides are associated with the cytosolic heat shock pro-
species.teins (Udono and Srivastava, 1993; Srivastava et al.,
1998). However, we were unable to detect antigenic
TAP Activity Influences Both the Cytosolicpeptides in extracts of hsp70 or hsp90 immunoprecipi-
and the ER Peptide Pooltates (data not shown). Because immunoprecipitated
To establish that the peptide fragments were part of thematerial could be biased by the specificity of the anti-
antigen presentation pathway and to assess potentialbodies used, we directly characterized the cytosolic
relationships between the cytosolic and ER peptides,high±molecular weight species by size-exclusion chro-
we analyzed cells with or without functional TAP. COSmatography (SEC-HPLC, Figure 4A). Each size-exclu-
cells were transfected with the n90-K-SHL8 antigenicsion fraction was acid extracted and analyzed for the
precursor in the absence or presence of the TAP inhibi-presence of antigenic peptides. The antigenic activity
tor ICP47. Analysis of the whole cell extracts by thewas detected in fractions 15 and 16 (Figure 4A). These
HPLC/trypsin method revealed the same cytosolic andfractions contained material in the 30±60 kDa range as
ER peptides as found in the FO-1 and HeLa cells above:shown by Ponceau S staining of fractionated proteins
K-SHL8, LK-SHL8, QLK-SHL8, as well as the late peaksafter denaturing polyacrylamide gel electrophoresis
(Figure 5A). When TAP transport was blocked by coex-(Figure 4B). Interestingly, Western blot analysis of the
pression of ICP47, there was a dramatic reduction in
same fractions showed that the bulk of hsp70 eluted in
the K-SHL8 activity and a concomitant increase in the
fractions 13±14, which did not contain detectable anti-
LK-SHL8 and QLK-SHL8 peaks as well as a shoulder
genic activity (Figure 4D). However, hsp27, another cyto- on the late peak, while the bulk of the late-eluting activity
solic heat shock protein, eluted primarily in fraction 16, in fractions 38±40 remained unchanged (Figure 5B).
which did contain the antigenic activity. But the anti- There was no detectable change in the SHL8 peptide
genic activity was not detected in anti-hsp27 immuno- peak, suggesting that this material may represent the
precipitates (data not shown), making it less likely that 1% activity detected in the absence of TAP function
hsp27 serves as a chaperone for cytosolic antigenic (Figure 2C), or it could have been generated during the
peptides. Further analysis of the antigenic activity in extraction procedure. The relative amounts of antigenic
fractions 15 and 16 of the size-exclusion column by peptides were estimated by comparison of serial dilu-
reverse-phase HPLC showed that this activity coeluted tions of each fraction with appropriate synthetic peptide
with the predominant LK-SHL8 decapeptide found in standard curves assayed under identical conditions.
the unfractionated cytosol. The other peptide activities TAP inhibition caused a 6- to 10-fold increase in LK-
detected in the unfractionated cytosol (Figure 3B) were SHL8 and QLK-SHL8 peptide concentrations and a simi-
not detected in fractions 15±16 of the size-exclusion lar decrease in the K-SHL8 peptide concentration recov-
chromatography. It is uncertain whether the other cyto- ered in the fractions (Figure 5C). We therefore infer that
solic peptides were bound to the same chaperone(s) the LK-SHL8 and the QLK-SHL8 peptides are cytosolic
but were lost during experimental manipulations or were substrates for TAP and that the K-SHL8 peptide is their
TAP-dependent product in the ER.bound to yet other molecules. We conclude that the
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Figure 5. Inhibition of TAP Activity Causes an Increase in Concentration of Cytosolic Peptides and a Decrease in Concentration of ER Peptides
The cytosolic QLK-SHL8 and LK-SHL8 peptides are transported into microsomes in a TAP- and ATP-dependent manner.
(A and B) COS cells were transfected with the n90K-SHL8 antigen precursor together with either (A) vector DNA or (B) the TAP inhibitor ICP47
encoding DNA by electroporation and were harvested 48 hr later. Whole-cell peptide extracts were prepared by boiling in 0.5 mL 10% formic
acid. Peptides smaller than 10 kDa were fractionated by HPLC and after trypsin treatment were assayed for B3Z T cell±stimulating activity.
In cells expressing ICP47, an increase or decrease in antigenic activity is indicated by the direction of arrowheads. No detectable change is
indicated by ªz.º
(C) The total relative concentration of QLK-SHL8, LK-SHL8, or K-SHL8 peptides recovered in the absence or presence of ICP47 was computed
from serial dilutions of active fractions with the SHL8 peptide as a standard.
(D) In vitro transport of QLK-SHL8 and LK-SHL8 synthetic peptides (100 fmol) was measured using microsomes prepared from wild-type
TAP1 or TAP2/2 animals with or without ATP. After 10 min, the microsomes were washed and digested with proteinase K or mock digested.
Translocated peptides in the microsomes were acid extracted and analyzed for B3Z-stimulating activity.
TAP Transports the Cytosolic assess the relationship between the K-SHL8 peptide
and its potential SHL8 cleavage product presented byProteolytic Intermediates
To directly establish that the cytosolic LK-SHL8 and the Kb MHC I, we analyzed extracts from cells coexpressing
the antigenic precursor and the vector alone, the irrele-QLK-SHL8 peptides were TAP substrates, we tested
these peptides in an in vitro transport assay (Shepherd vant Kd MHC I, or the Kb MHC I. In striking contrast to
the virtually identical antigenic peptide profiles in cellset al., 1993). Microsomes were prepared from wild-type
TAP1 and TAP1 knockout mice and used for transport expressing the vector alone or the irrelevant Kd MHC I,
where the SHL8 peptide was barely detected (Figuresof synthetic LK-SHL8 and QLK-SHL8 peptides as de-
scribed in Experimental Procedures. Transport of these 6A and 6C), the SHL8 peptide peak became the most
abundant species in cells expressing Kb, even spillingpeptides into the microsomes required both ATP and a
functional TAP molecule (Figure 5D). Most importantly, over into the later fractions (Figure 6B). By assaying
1:100 dilution of each fraction, we determined that 98%the peptide recovery, representing z10% of the original
100 fmol input, was completely resistant to treatment of the SHL8 activity eluted in fractions 14±15, but the
spillover of the remaining 2% obscured all other anti-of the microsomes with proteinase-K, demonstrating
that the peptides were actually translocated into the genic peptides, including the LK-SHL8 and QLK-SHL8
peptides, that elute in the later fractions (Figure 6C,lumen of the microsomes. This in vitro result therefore
supports the analysis of the whole cell extracts and inset). Most interestingly, the K-SHL8 peptide peak,
which was the predominant species in cells without Kbsubcellular fractions above and establishes that both
the LK-SHL8 and QLK-SHL8 proteolytic intermediates MHC I, was dramatically reduced in the presence of Kb
MHC I (Figure 6B versus Figures 6A and 6C). Occasion-were bonafide substrates for TAP-mediated transport
into the lumen of the ER. ally a new peak (marked by an asterisk, Figure 6B) was
also observed to elute in fraction 10±11, between the
K-SHL8 and the SHL8 peaks. The peptide structureKb MHC Profoundly Influences Recovery
of the K-SHL8 and the SHL8 Peptides corresponding to this activity is not known because
none of the SHL8 analogs with up to six additional aminoThe K-SHL8 nonapeptide was by far the predominant
antigenic species detected in the ER (Figure 3C). To acids elute at this position. Because shorter SHL8
Proteolytic Events during MHC I Antigen Processing
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Figure 6. Coexpression of Kb Specifically Affects the Yield of K2SHL8 and SHL8 Peptides
(A±C) Peptides were extracted from COS cells transfected with the n90K-SHL8 construct together with (A) vector alone, (B) Kb MHC I, or (C)
Kd MHC I cDNA and analyzed as in Figure 3. The inset in (B) depicts the antigenic activity in the 1:100 dilution of the same HPLC fractions.
(D) The total concentration of K-SHL8 and SHL8 peptides recovered from cells cotransfected with the n90-K-SHL8 precursor and the vector,
Kb or Kd cDNAs. Serial dilutions of appropriate fractions were compared with trypsin-treated K-SHL8 and SHL8 synthetic peptides as standards,
respectively.
analogs are inactive in the T cell assay, the asterisk peptide, but the SHL8 activity was not detected (Figure
7A). There was little change in this profile when Kb aactivity could be due to some other chemical modifica-
tion. Notably, no significant differences were detected chain was also expressed in the cells (Figure 7B), despite
the fact that the Kb heavy chain was readily detectedin the cytosolic QLK-SHL8 or the late peaks. We conclude
that the profound reciprocal changes in the K-SHL8 by Western blot (Figure 7D). By contrast, when both the
Kb heavy chain and the b2-microglobulin were ex-and SHL8 peptides were specific to Kb and occurred in
the ER. pressed in the FO-1 cells, the K-SHL8 peptide was no
longer detected and only the SHL8 peptide was recov-To quantitate the change in the recovery of the
K-SHL8 and SHL8 peptides, serial dilutions of each ered in the extract. Taken together, these results support
the notion that the K-SHL8 peptide was converted to theHPLC fraction were assayed in parallel with appropriate
standard curves. The results confirmed the reciprocal SHL8 peptide and that this conversion occurred only in
presence of the intact Kb MHC I molecule.relationship in the recovery of the K-SHL8 and SHL8
peptides in the absence or presence of Kb MHC I (Figure
6D). Relative to cells expressing the antigenic precursor Discussion
with the vector alone or the irrelevant Kd MHC I, in Kb
cells there was a 10-fold reduction in the recovery of Using a novel method to analyze antigenic peptides, we
found that the antigen processing pathway generatedK-SHL8 peptide and at least a 1000-fold enhancement in
the recovery of SHL8 peptide. We conclude that the a heterogeneous set of proteolytic intermediates in the
cytosol that was associated with high±molecular weightexpression of Kb MHC I correlated not only with the
expected increase in the SHL8 octapeptide, but also material. The N-terminally extended peptides were
transported via TAP into the ER and were cleaved towith a decrease in the K-SHL8 nonapeptide.
To determine if this profound influence of Kb MHC I the optimal peptide in the presence of the restricting
MHC I molecule. Antigen processing therefore occurson the reciprocal recovery of the K-SHL8 and SHL8
peptides required the intact MHC I molecule or if it could both in the cytosolic and the ER compartments and may
have evolved to efficiently satisfy the varying peptidebe mediated by the Kb heavy chain alone, we introduced
into the n90-K-SHL8-expressing, b2-microglobulin-neg- binding preferences of polymorphic MHC I molecules.
ative FO-1 cells the Kb only or both Kb and b2-microglob-
ulin. The cell extracts were then analyzed by the HPLC/ Assays for Proteolytic Intermediates in the Antigen
Processing Pathwaytrypsin method for the K-SHL8 and SHL8 peptides that
elute within the first 24 fractions. As seen below, an Biochemical analysis of the pathway that makes the
processed peptides available to the peptide-receptiveextract of FO-1 cells lacking Kb contained the K-SHL8
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Figure 7. The Intact Kb/b2-Microglobulin
Heterodimer Is Required for Generation of the
SHL8 from Its K-SHL8 Precursor
(A and B) Peptide extracts from FO-1 cells
stably expressing n90K-SHL8 antigen (A)
without or (B) with the Kb heavy chain were
prepared and analyzed as described in Fig-
ure 3.
(C) Analysis of peptide extracts from the n90-
K-SHL8 transfected FO-1 cells that were
coinfected with recombinant vaccinia ex-
pressing Kb and b2-microglobulin.
(D) Western blot analysis for Kb a chain ex-
pression in four different FO-1/n90-K-SHL8
clones transfected with Kb heavy chain. The
indicated cells were lysed in NP-40 and 105
cell equivalents were separated by 12% SDS-
PAGE gels. Proteins were transferred onto
nitrocellulose membranes and probed with a
Kb specific polyclonal rabbit antiserum. Mo-
lecular weight markers are shown on left.
MHC I in the ER has so far been limited by the sensitivity blocked by ICP47 in vivo (Figure 5). Moreover, these
of conventional methods available for detecting anti- peptides were directly transported into the microsomal
genic peptides. The standard assays based upon T cell lumen in vitro in a TAP- and ATP-dependent manner
activation are adequate for analysis of the final MHC (Figure 5). Notably, except for a change in the shoulder,
I±bound processed peptide products but are remarkably blocking TAP did not affect the antigenic peptides that
insensitive for detecting antigenic analogs with addi- eluted later in the HPLC profiles, indicating that TAP
tional flanking residues (Figure 1). This bias is expected does not transport all proteolytic intermediates. Deter-
because the T cells are elicited by the final processed mination of the molecular structures of the peptides
peptide/MHC I complexes in the animals and was the contained within these late peaks should reveal whether
apparent cause for the failure of previous attempts to the failure to be transported was due to their size, which
identify these proteolytic intermediates (Falk et al., 1990; may have exceeded the capacity of TAP, or their inability
Malarkannan et al., 1995). The HPLC/trypsin method, as to associate with the putative cytosolic chaperone(s).
well as the design of the antigenic precursor where the Alternatively, it is possible that the longer peptides
optimal SHL8 peptide could be released in a single step, were the immediate precursors to the LK-SHL8 and
increased the sensitivity of the T cell assays by several QLK-SHL8 peptides. The potential precursor/product
orders of magnitude and allowed the detection of the relationship between the late peaks and the 10- to 11-
elusive proteolytic intermediates in living cells. We antic- mer TAP substrates was not addressed in this analysis
ipate that further improvements in this methodology will but is an attractive and testable hypothesis which sug-
also permit the detection of proteolytic intermediates gests that cytosolic antigen processing may be a
when the antigenic peptides are located in sequence multistep process involving different proteolytic mecha-
contexts containing both N- and C-terminal flanking res- nisms (Craiu et al., 1997; Glas et al., 1998; Serwold and
idues (T. Serwold and N. S., unpublished data). Shastri, 1999).
The antigenic peptides detected in the cytosol were
Antigen Processing in the Cytosol
not free but were recovered in a high±molecular weight
At least six discrete proteolytic intermediates were de-
fraction, which did not include the previously described
tected in the cytosol (Figure 3B). Notably, this heteroge-
heat shock proteins (Figures 3 and 4). Ignoring technicalneous set of cytosolic peptides did not include the SHL8
reasons such as the differences in cell types, the anti-peptide, which is one of the most widely studied pep-
genic peptides analyzed, or the sensitivity of the assaystides presented by the Kb MHC molecule. This result
employed to detect them, two interesting possibilitiesclearly shows that proteolysis of the antigenic precursor
may account for this disparity. First, proteolytic interme-in the cytosol does not generate detectable amounts of
diates generated from different antigenic precursorsthe exactly cleaved peptides that are eventually pre-
may associate with distinct cytosolic chaperones. Onesented by the MHC I molecule, and it could explain
might expect a difference between transmembrane pro-why these peptides have been difficult to find even in
teins such as the n90-K-SHL8 precursor, which couldprolonged in vitro digests with the proteasome (Dick et
be retrieved from the ER for proteolysis in the cytosol,al., 1994; Niedermann et al., 1995). Our findings are also
and other proteins that are synthesized and degradedconsistent with a previous study that indicated that the
in the cytosol itself (Skipper et al., 1996; Snyder et al.,final peptide products presented by the MHC I are often
1997). Second, distinct chaperone(s) may carry out dif-poor substrates in in vitro transport assays without addi-
ferent functions, such as ferrying the proteolytic frag-tional flanking residues (Neisig et al., 1995). We show
ments between different proteases and from the prote-that the LK-SHL8 and the QLK-SHL8 peptides were
ase(s) to the TAP complex. Because the LK-SHL8the actual substrates for TAP transport because their
concentrations increased in cell extracts when TAP was peptide was actually transported by TAP, we speculate
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that the high±molecular weight material it was associ- must exist that rapidly degrades the antigenic precur-
sors that fail to find a niche in the antigen-binding grooveated with could be the cytosolic chaperone that trans-
ports peptides to TAP, although the possibility that this of the available MHC I molecules.
is a protease cannot be ruled out. Efforts to identify this
material are in progress. Compartmentalized Proteolysis Can Improve
Antigen Processing Efficiency
The distinct proteolytic products described here sug-Role of MHC I during Antigen Processing
gest a solution to the efficiency conundrum posed byin the ER
the postulate that peptides presented by MHC I areThe influence of the Kb MHC I on the recovery of the final
generated in the cytosol prior to their transport andSHL8 octapeptide product versus the longer K-SHL8
binding to MHC I in the ER. Generating the exactlynonapeptide found exclusively in the ER was striking.
cleaved peptides in the cytosol, without knowledge ofCoexpression of the Kb but not Kd or other MHC I mole-
which polymorphic MHC I molecules await their arrivalcules in cells expressing the antigenic precursor led to
in the ER, can be an expensive undertaking. Consideringa dramatic increase in SHL8 octapeptide and a concomi-
an extreme example, a set of 379 random 8-mers musttant decrease in the K-SHL8 nonapeptide in cell extracts
be generated from the 386 residue ovalbumin protein(Figure 6). The effect of Kb was specific for the K-SHL8
to ensure that the exact SL8 octapeptide is among thosepeptide found exclusively in the ER and did not affect the
available for binding to Kb MHC I in the ER. Yet, becausecytosolic QLK-SHL8 peptide nor the peptides contained
the same SL8 peptide with an additional N-terminal resi-within the late peaks. Furthermore, the loss of K-SHL8
due is also presented by the Db MHC I molecule (Malar-peptide occurred only in the presence of the Kb a chain
kannan et al., 1995), the cells must also generate anand b2-microglobulin, indicating that this effect required
additional 378 random 9-mers to ensure that the X-SL8the complete Kb heterodimer. In other experiments, a
nonamer will be available if the Db MHC I was in the ER.similar increase in SHL8 and a decrease in K-SHL8 re-
Given that cells simultaneously process thousands ofcovery was observed with mutant Kb MHC I molecules
different proteins, generating sets of exact 8- to 11-merlacking the cytoplasmic tail or the transmembrane re-
peptides in the cytosol would result in an enormousgion (data not shown). Taken together, these findings
and eventually wasteful pool of peptides. However, thisstrongly suggest that the K-SHL8 peptide is the immedi-
waste can be largely obviated if longer peptides wereate precursor for the SHL8 octapeptide and that its con-
generated in the cytosol and trimmed to fit the availableversion depends upon the antigen-binding function of
MHC molecules in the ER. In the model system de-the Kb MHC I molecule.
scribed here, the LK-SHL8 peptide could yield eitherHow does Kb MHC I influence the conversion of the
the SHL8 or the K-SHL8 peptides depending uponK-SHL8 to the SHL8 peptide? The simplest explana-
whether the Kb or Db MHC I were available in the ER.tion for this result is that the MHC I molecules serve
Thus, MHC I±dependent cleavage of extra flanking resi-as templates for the final proteolytic event, as was
dues can significantly increase the efficiency with whichsuggested by Rammensee's group almost a decade
optimal peptide/MHC complexes can be generated fromago when they first showed that antigenic peptides in
a given precursor.cell extracts were detected only in presence of appro-
priate MHC I molecules (Falk et al., 1990). Since then,
Experimental Proceduresseveral studies have inferred from functional assays that
N-terminal rather than C-terminal flanking residues can
Cell Linesbe cleaved from antigenic precursors in the ER (Snyder
The SHL8/Kb-specific, lacZ-inducible, B3Z T hybridoma, Kb L, and
et al., 1994; Powis et al., 1996; Yellen-Shaw et al., 1997). COS cell lines have been described (Karttunen et al., 1992). The
Our results provide definitive identification of proteolytic b2m negative FO1 melanoma cell line was generously provided by
intermediates in the cytosol and the ER during antigen Dr. S. Ferrone (D'Urso et al., 1991). FO1 and HeLa cells expressing
the n90K-SHL8 6 Kb were generated by electroporation. Positiveprocessing. Changes in their concentration and struc-
clones were identified by their ability to stimulate B3Z T cells directlyture provide direct evidence that not only does N-termi-
or when transfected with Kb cDNA or infected with vaccinia (a kindnal trimming actually occur in the ER but that this amino-
gift of J. Yewdell) expressing Kb and b2m at a multiplicity of infection
peptidase activity is profoundly influenced by the MHC of 1.
I molecules. We have also observed that similar MHC
I-dependent cleavages occur in isolated microsomes Plasmid DNAs, Synthetic Peptides, and Antibodies
Plasmids encoding OVA, OVA253±386, n90K-SHL8, M-SIINFEHL, or(N. B. and N. S., unpublished data), which may allow
es-SHL8 have been described or were prepared using syntheticaccess to the molecules that mediate these rapid pro-
oligonucleotides (Shastri and Gonzalez, 1993). The Kd and ICP47teolytic events. It should also be interesting to test the
cDNAs (kind gifts of Drs. T. Hansen and D. Johnson, respectively)
potential role of the ERp57 molecule in ER trimming were subcloned into the pcDNAI vector. Synthetic peptides were
events, because it was recently discovered to be a mem- prepared by Dr. David King (UC-Berkeley, CA), purified (.99.9%)
ber of the TAP/tapasin/MHC I complex (Hughes and by HPLC, and confirmed by mass spectrometry. The rabbit anti-Kb
was kindly provided by Dr. E. Song.Cresswell, 1998) and has been reported to possess pro-
tease activity (Otsu et al., 1995). Furthermore, note that
T Cell Activation Assaysthe large, .100-fold difference in the steady state con-
SHL8/Kb-specific B3Z response was measured as the b-galactosi-centrations of the K-SHL8 versus the Kb-bound SHL8
dase (lacZ) activity induced upon T cell activation. B3Z cells (1 3
peptides demonstrates that in the absence of peptide 105) were cocultured overnight with 3±5 3 104 transfected APC or
binding to MHC I, the proteolytic intermediates do not Kb L cells and synthetic peptides or HPLC fractions. To detect
N-terminally extended SHL8 analogs, synthetic peptides or HPLCaccumulate in the cells. Therefore, another mechanism
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